Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ImPACCT: Imatinib in Mesenchymal Colon Cancer
NCT02685046Phase 2Terminated
- Start
- Apr 2016
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of imatinib in colon cancer. Started Apr 2016; status: terminated.
02
Drugs
03
Conditions
colon cancer
Beyond the preview
Go deeper on NCT02685046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02685046.